Dianne E. Schwartz

718 total citations
10 papers, 574 citations indexed

About

Dianne E. Schwartz is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, Dianne E. Schwartz has authored 10 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pharmacology and 2 papers in Surgery. Recurrent topics in Dianne E. Schwartz's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Dianne E. Schwartz is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Dianne E. Schwartz collaborates with scholars based in United States and Norway. Dianne E. Schwartz's co-authors include Kenneth A. Schwartz, Anthony DeFranco, Kimberly Barber, Mathew J. Reeves, Victor L. Serebruany, Dan Atar, Alex I. Malinin, Alex Pokov, Ehtisham Mahmud and Anthony C. De Franco and has published in prestigious journals such as Blood, Journal of Applied Physiology and The American Journal of Cardiology.

In The Last Decade

Dianne E. Schwartz

10 papers receiving 548 citations

Peers

Dianne E. Schwartz
JS Yudkin United Kingdom
Sundararajan Srikanth United States
Előd Papp Hungary
E M Hoare United Kingdom
Dianne E. Schwartz
Citations per year, relative to Dianne E. Schwartz Dianne E. Schwartz (= 1×) peers A Del Ponte

Countries citing papers authored by Dianne E. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Dianne E. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianne E. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianne E. Schwartz more than expected).

Fields of papers citing papers by Dianne E. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianne E. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianne E. Schwartz. The network helps show where Dianne E. Schwartz may publish in the future.

Co-authorship network of co-authors of Dianne E. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Dianne E. Schwartz. A scholar is included among the top collaborators of Dianne E. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianne E. Schwartz. Dianne E. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schwartz, Kenneth A., et al.. (2008). Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. Journal of Translational Medicine. 6(1). 46–46. 56 indexed citations
2.
Schwartz, Kenneth A., Dianne E. Schwartz, Kimberly Barber, Matthew B. Reeves, & Anthony DeFranco. (2007). Non-Compliance Is the Predominant Cause of Aspirin Resistance.. Blood. 110(11). 932–932. 1 indexed citations
3.
Malinin, Alex I., Alex Pokov, Anthony DeFranco, et al.. (2006). Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study. Thrombosis Research. 119(3). 277–284. 184 indexed citations
4.
Schwartz, Kenneth A., et al.. (2005). Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. The American Journal of Cardiology. 95(8). 973–975. 163 indexed citations
5.
Schwartz, Kenneth A., et al.. (2005). Minimal Frequency of Aspirin Resistance after Observed Aspirin Ingestion.. Blood. 106(11). 551–551. 2 indexed citations
6.
Schwartz, Kenneth A., et al.. (2004). Relationships between Risk Factors for Coronary Artery Disease and Aspirin Resistance.. Blood. 104(11). 1854–1854. 1 indexed citations
7.
Schwartz, Kenneth A., et al.. (2002). A new method for measuring inhibition of platelet function by nonsteroidal antiinflammatory drugs. Journal of Laboratory and Clinical Medicine. 139(4). 227–233. 16 indexed citations
8.
Schwartz, Kenneth A., ZY Li, Dianne E. Schwartz, Thomas G. Cooper, & W. Emmett Braselton. (2002). Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction. Journal of Applied Physiology. 93(2). 746–751. 41 indexed citations
9.
Jl, Richard, Pierre Ducimetière, Guillaume Bonnaud, et al.. (1977). [Incidence and evaluation of the risk of coronary disease. Prospective study in Paris].. PubMed. 70(5). 531–40. 6 indexed citations
10.
Schwartz, Dianne E.. (1974). Corneal Sensitivity in Diabetics. Archives of Ophthalmology. 91(3). 174–178. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026